流感相关与COVID-19相关肺曲霉病的纵向真菌学特征分析
该回顾性队列纳入比利时某三级ICU 2009-2024年间180例需机械通气的成人 probable/proven IAPA(n=68)或CAPA(n=112)患者,分析698份BAL样本。线性混合效应模型显示BAL GM值在诊断后随时间显著下降,存活者下降更陡(交互作用p<0.05)。贝叶斯联合模型显示,GM随时间每升高1个单位,ICU入科后30天(aHR 1.19,p=0.02)和90天(aHR 1.19,p=0.007)死亡风险均增加19%。持续BAL培养阳性也与更差结局相关。BAL GM动力学可能是此类患者的潜在预后生物标志物。
要点
- 在需机械通气的IAPA/CAPA患者中,BAL GM随时间每升高1个单位,30天死亡风险增加19%(aHR 1.19,p=0.02)。
- 同一队列中,BAL GM随时间每升高1个单位,90天死亡风险增加19%(aHR 1.19,p=0.007)。
- BAL GM值在曲霉病诊断后随时间显著下降,存活者下降幅度更陡(交互作用p<0.05)。
- 持续BAL曲霉培养阳性与更差结局相关。
- BAL GM动力学可能是IAPA/CAPA患者的潜在预后生物标志物,早期且持续升高者死亡风险增加。
适用人群与场景
- 2009-2024年比利时某三级ICU的成人患者,需机械通气,确诊 probable/proven IAPA(n=68)或CAPA(n=112),共180例。
研究设计与关键结果
- 研究类型:回顾性队列,单中心(比利时某三级ICU),2009-2024年,纳入180例需机械通气的成人 probable/proven IAPA(n=68)或CAPA(n=112)患者,共分析698份BAL样本。
- BAL GM值在曲霉病诊断后随时间显著下降,存活者下降更陡(交互作用p<0.05)。
- 贝叶斯联合模型(调整年龄、Charlson Comorbidity Index和免疫抑制状态)显示,GM随时间每升高1个单位,30天死亡风险增加19%(aHR 1.19,p=0.02),90天死亡风险增加19%(aHR 1.19,p=0.007)。
- 持续BAL曲霉培养阳性与更差结局相关。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在需机械通气的IAPA/CAPA患者中,作者认为BAL GM动力学可作为潜在预后生物标志物,早期且持续升高提示死亡风险增加。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Influenza- and COVID-19-associated pulmonary aspergillosis (IAPA and CAPA respectively) are associated with increased mortality in critically ill patients. We evaluated whether longitudinal bronchoalveolar lavage (BAL) galactomannan (GM) dynamics predict clinical outcomes in these patients.
METHODS: In a retrospective cohort (2009-2024) at a tertiary care ICU in Belgium, 180 adult patients with probable/proven IAPA (n = 68) or CAPA (n = 112) requiring mechanical ventilation were included. A total of 698 BAL samples were analysed. GM optical density values were modelled using linear mixed-effects models (10- and 30-day follow-up windows), with outcome measures at 30 and 90 days. Bayesian joint models linked longitudinal GM trends with time-to-death, adjusting for age, Charlson Comorbidity Index (CCI) and immunosuppression. Associations between Aspergillus culture results dynamics and mortality were also assessed.
RESULTS: In general, BAL GM values declined significantly over days after diagnosis of aspergillosis, with steeper reductions in survivors (interaction p < 0.05). Joint models revealed each unit increase in GM over time corresponded to a 19% higher hazard of death at both 30 (aHR 1.19, p = 0.02) and 90 days (aHR 1.19, p = 0.007) after ICU admission. Persistent BAL culture positivity also correlated with worse outcomes.
CONCLUSIONS: In this large virus-associated pulmonary aspergillosis cohort, BAL GM kinetics emerged as a potential prognostic biomarker. Early and sustained increases in BAL GM values identify patients at increased risk of mortality.
参考来源
- Delanote V, Heylen J, Lauwers HM, et al. Longitudinal mycological profiling of influenza-associated and COVID-19-associated pulmonary aspergillosis. Crit Care. 2026. PMID: 41508132. doi:10.1186/s13054-025-05830-9
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。